Existing drug could aid spinal injury recovery

Spinal injury

Scientists investigating potential drugs to improve recovery from spinal cord injury have uncovered a promising route to new treatments.

Researchers tested more than 1000 potential drugs and identified that an existing one – cimetidine – improved spinal repair in zebrafish.

The drug also helped improve recovery of movement and reduce the extent of spinal cord damage when tested in spinal-injured mice. The findings shed new light on the biological pathways involved in recovery from spinal cord injury, experts say.

Sudden impacts on the spinal cord – for example, those caused by a car accident – can lead to life-long injuries. Healing can be inefficient due to inflammation caused by an overreaction of the body’s immune system, which normally protects against infections.

However, drugs that reduce inflammation by suppressing the whole immune response also inhibit the immune cells which promote repair.

The University of Edinburgh-led study tested multiple drugs in zebrafish larvae for their ability to prevent excessive inflammation during an immune response.

Scientists discovered that cimetidine acts by helping to regulate levels of histamine – a chemical released by the immune system which is involved in inflammatory reactions – in the body.

The findings have enabled the team to pinpoint a specific signalling pathway that moderates the immune response after spinal injury to support repair.

The research team included scientists from the University of Edinburgh, the Research Institute of the McGill University Health Centre and Technische Universität Dresden.

“The ability to screen a large number of drugs using the zebrafish model has revealed an important target for future research into spinal cord repair,” commented Professor Catherina Becker, Centre for Discovery Brain Sciences at the University of Edinburgh and the Center for Regenerative Therapies Dresden (CRTD) at TU Dresden. “Our findings open the door to potential new treatments that can moderate inflammation and improve recovery from spinal injury.”

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free